BVF PARTNERS L P/IL Insider Trading $CTIC CTI BIOPHARMA CORP
Get free email notifications about insider trading for BVF PARTNERS L P/IL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of BVF PARTNERS L P/IL. BVF PARTNERS L P/IL is in Capstone Therapeutics Corp. ($CAPS) and 10% Owner in CTI BIOPHARMA CORP ($CTIC) and Director in CTI BIOPHARMA CORP ($CTIC) and 10% Owner in XOMA Corp ($XOMA) and Director in XOMA Corp ($XOMA) and 10% Owner in ARQULE INC ($ARQL) and 10% Owner in INFINITY PHARMACEUTICALS, INC. ($INFI) and in FIVE PRIME THERAPEUTICS, INC. ($FPRX) and 10% Owner in FIVE PRIME THERAPEUTICS, INC. ($FPRX) and in CYTOKINETICS INC ($CYTK) and 10% Owner in CYTOKINETICS INC ($CYTK) and 10% Owner in GLYCOMIMETICS INC ($GLYC) and 10% Owner in CONCERT PHARMACEUTICALS, INC. ($CNCE) and 10% Owner in Syndax Pharmaceuticals Inc ($SNDX) and in Eledon Pharmaceuticals, Inc. ($NVUS) and in ChemoCentryx, Inc. ($CCXI) and 10% Owner in ChemoCentryx, Inc. ($CCXI) and 10% Owner in IMMUNE DESIGN CORP. ($IMDZ) and 10% Owner in Calithera Biosciences, Inc. ($CALA) and 10% Owner in Principia Biopharma Inc. ($PRNB) and 10% Owner in PIERIS PHARMACEUTICALS, INC. ($PIRS) and 10% Owner in Xenon Pharmaceuticals Inc. ($XENE) and 10% Owner in Nivalis Therapeutics, Inc. ($NVLS) and 10% Owner in Merus N.V. ($MRUS) and in IDEAYA Biosciences, Inc. ($IDYA) and 10% Owner in IDEAYA Biosciences, Inc. ($IDYA) and Director in Rain Therapeutics Inc. ($RAIN) and Director in Olema Pharmaceuticals, Inc. ($OLMA) and Director in Kymera Therapeutics, Inc. ($KYMR).
BVF PARTNERS L P/IL in CTI BIOPHARMA CORP
Trading Symbol: CTICIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BVF PARTNERS L P/IL: Director, 10% Owner
Holdings: 4,085,933 shares
Current Value: $19,081,307
Latest Transaction: Apr 05 2021
$CTIC Market Capitalization: $129.36M
$CTIC Previous Close: $4.67
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of BVF PARTNERS L P/IL in CTI BIOPHARMA CORP
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALPN, ARQL, CALA, CAPS, CCXI, CNCE, CTIC, CYTK, ELDN, FPRX, GLYC, IDYA, IMDZ, INFI, KYMR, MRUS, OLMA, PIRS, PRNB, RAIN, SNDX, XENE, XOMA
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 05 2021 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | Director | Option Exercise | P | 0.00 | 17 | 0 | 17 | |
Apr 05 2021 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | Director | Option Exercise | P | 0.00 | 239 | 0 | 239 | |
Apr 05 2021 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | Director | Option Exercise | P | 0.00 | 344 | 0 | 344 | |
Apr 05 2021 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | Director | Buy | P | 2.50 | 5,171 | 12,928 | 488,879 | 483.7 K to 488.9 K (+1.07 %) |
Apr 05 2021 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | Director | Buy | P | 2.50 | 950,016 | 2,375,040 | 3,059,296 | 2.1 M to 3.1 M (+45.04 %) |
Apr 05 2021 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | Director | Buy | P | 2.50 | 1,044,813 | 2,612,033 | 4,085,933 | 3 M to 4.1 M (+34.36 %) |
Mar 12 2021 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | Director | Option Exercise | A | 3.30 | 80,000 | 264,000 | 80,000 | |
Mar 04 2020 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Option Exercise | P | 10,000.00 | 12 | 120,000 | 12 | |
Mar 04 2020 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Option Exercise | P | 10,000.00 | 87 | 870,000 | 191 | |
Mar 04 2020 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Option Exercise | P | 10,000.00 | 841 | 8,410,000 | 1,250 | |
Mar 04 2020 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Option Exercise | P | 10,000.00 | 981 | 9,810,000 | 1,594 | |
Mar 04 2020 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Option Exercise | X | 10,000.00 | 104 | 1,040,000 | 104 | |
Mar 04 2020 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Option Exercise | X | 10,000.00 | 104 | 1,040,000 | 0 | |
Mar 04 2020 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Option Exercise | X | 10,000.00 | 409 | 4,090,000 | 409 | |
Mar 04 2020 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Option Exercise | X | 10,000.00 | 409 | 4,090,000 | 0 | |
Mar 04 2020 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Option Exercise | X | 10,000.00 | 613 | 6,130,000 | 613 | |
Mar 04 2020 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Option Exercise | X | 10,000.00 | 613 | 6,130,000 | 0 | |
Feb 12 2018 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Option Exercise | A | 0.00 | 2,280 | 0 | 2,280 | |
Feb 12 2018 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Option Exercise | A | 0.00 | 2,280 | 0 | 2,280 | |
Feb 12 2018 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Option Exercise | A | 0.00 | 1,024 | 0 | 1,024 | |
Feb 12 2018 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Option Exercise | A | 0.00 | 1,024 | 0 | 1,024 | |
Feb 12 2018 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Option Exercise | A | 0.00 | 3,640 | 0 | 3,640 | |
Feb 12 2018 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Option Exercise | A | 0.00 | 3,640 | 0 | 3,640 | |
Feb 12 2018 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Option Exercise | A | 0.00 | 5,631 | 0 | 5,631 | |
Feb 12 2018 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Option Exercise | A | 0.00 | 5,631 | 0 | 5,631 | |
Feb 12 2018 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Option Exercise | D | 0.00 | 49 | 0 | 0 | |
Feb 12 2018 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Option Exercise | D | 0.00 | 49 | 0 | 0 | |
Feb 12 2018 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Option Exercise | D | 0.00 | 48 | 0 | 0 | |
Feb 12 2018 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Option Exercise | D | 0.00 | 48 | 0 | 0 | |
Feb 12 2018 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Option Exercise | D | 0.00 | 197 | 0 | 0 | |
Feb 12 2018 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Option Exercise | D | 0.00 | 197 | 0 | 0 | |
Feb 12 2018 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Option Exercise | D | 0.00 | 281 | 0 | 0 | |
Feb 12 2018 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Option Exercise | D | 0.00 | 281 | 0 | 0 | |
Feb 12 2018 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.00 | 699,225 | 2,097,675 | 1,295,582 | 596.4 K to 1.3 M (+117.25 %) |
Feb 12 2018 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.00 | 699,225 | 2,097,675 | 1,295,582 | 596.4 K to 1.3 M (+117.25 %) |
Feb 12 2018 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.00 | 483,708 | 1,451,124 | 483,708 | 0 to 483.7 K |
Feb 12 2018 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.00 | 483,708 | 1,451,124 | 483,708 | 0 to 483.7 K |
Feb 12 2018 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.00 | 2,109,280 | 6,327,840 | 2,109,280 | 0 to 2.1 M |
Feb 12 2018 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.00 | 2,109,280 | 6,327,840 | 2,109,280 | 0 to 2.1 M |
Feb 12 2018 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.00 | 3,041,120 | 9,123,360 | 3,041,120 | 0 to 3 M |
Feb 12 2018 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 3.00 | 3,041,120 | 9,123,360 | 3,041,120 | 0 to 3 M |
Feb 12 2018 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Sell | D | 0.00 | 1,487,294 | 0 | 596,357 | 2.1 M to 596.4 K (-71.38 %) |
Feb 12 2018 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Sell | D | 0.00 | 1,487,294 | 0 | 596,357 | 2.1 M to 596.4 K (-71.38 %) |
Feb 12 2018 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Sell | D | 0.00 | 651,074 | 0 | 0 | 651.1 K to 0 (-100.00 %) |
Feb 12 2018 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Sell | D | 0.00 | 651,074 | 0 | 0 | 651.1 K to 0 (-100.00 %) |
Feb 12 2018 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Sell | D | 0.00 | 2,295,083 | 0 | 0 | 2.3 M to 0 (-100.00 %) |
Feb 12 2018 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Sell | D | 0.00 | 2,295,083 | 0 | 0 | 2.3 M to 0 (-100.00 %) |
Feb 12 2018 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Sell | D | 0.00 | 3,566,549 | 0 | 0 | 3.6 M to 0 (-100.00 %) |
Feb 12 2018 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Sell | D | 0.00 | 3,566,549 | 0 | 0 | 3.6 M to 0 (-100.00 %) |
Jun 14 2017 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Option Exercise | C | 0.00 | 536 | 0 | 49 | |
Jun 14 2017 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Option Exercise | C | 0.00 | 513 | 0 | 48 | |
Jun 14 2017 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Option Exercise | C | 0.00 | 2,115 | 0 | 197 | |
Jun 14 2017 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Option Exercise | C | 0.00 | 3,011 | 0 | 281 | |
Jun 14 2017 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Option Exercise | P | 0.00 | 585 | 0 | 585 | |
Jun 14 2017 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Option Exercise | P | 0.00 | 561 | 0 | 561 | |
Jun 14 2017 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Option Exercise | P | 0.00 | 2,312 | 0 | 2,312 | |
Jun 14 2017 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Option Exercise | P | 0.00 | 3,292 | 0 | 3,292 | |
Jun 14 2017 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Buy | C | 0.00 | 357,333 | 0 | 2,083,651 | 1.7 M to 2.1 M (+20.70 %) |
Jun 14 2017 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Buy | C | 0.00 | 342,000 | 0 | 651,074 | 309.1 K to 651.1 K (+110.65 %) |
Jun 14 2017 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Buy | C | 0.00 | 1,410,000 | 0 | 2,295,083 | 885.1 K to 2.3 M (+159.31 %) |
Jun 14 2017 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Buy | C | 0.00 | 2,007,333 | 0 | 3,566,549 | 1.6 M to 3.6 M (+128.74 %) |
Jan 11 2016 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.22 | 58,613 | 71,338 | 17,263,200 | 17.2 M to 17.3 M (+0.34 %) |
Jan 11 2016 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.22 | 32,571 | 39,642 | 3,090,744 | 3.1 M to 3.1 M (+1.07 %) |
Jan 11 2016 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.22 | 90,049 | 109,599 | 8,850,836 | 8.8 M to 8.9 M (+1.03 %) |
Jan 11 2016 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.22 | 186,314 | 226,763 | 15,592,160 | 15.4 M to 15.6 M (+1.21 %) |
Jan 11 2016 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.22 | 8,091 | 9,848 | 17,204,587 | 17.2 M to 17.2 M (+0.05 %) |
Jan 11 2016 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.22 | 29,655 | 36,093 | 3,058,173 | 3 M to 3.1 M (+0.98 %) |
Jan 11 2016 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.22 | 87,747 | 106,797 | 8,760,787 | 8.7 M to 8.8 M (+1.01 %) |
Jan 11 2016 | CTIC | CTI BIOPHARMA CORP | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 1.22 | 508,287 | 618,636 | 15,405,846 | 14.9 M to 15.4 M (+3.41 %) |
Page: 1